News
Diabetes drug Ozempic will cost half-price for US patients paying cash - The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes pa ...
Novo is far from the only big pharma company bolstering DTC medicine offerings. Novo’s main rival in the GLP-1RA arena, Eli ...
The company is the latest facing historic losses as pharmaceutical firms compete to develop a weight-loss pill.
An influential pediatrics group in the U.S. has diverged from the CDC’s recently updated child immunization schedule and ...
BBIO's Acoramidis shows promise but faces tough competition. Diverse pipeline & catalysts ahead, but valuation relies on ...
One of the highest yields you can get right now is from Pfizer (NYSE: PFE). The healthcare giant offers a yield of 6.8%, ...
With Trump's backing, the pharma industry is leaning into the idea of more "direct-to-consumer" sales. But experts say the ...
The American Academy of Pediatrics released its updated recommendations for vaccines on Tuesday, including Covid-19 shots for ...
For the first time in 30 years, the American Academy of Pediatrics is substantially diverging from U.S. government vaccine ...
We reviewed the science, listened to the experts, and acted,” said HHS Secretary Robert F. Kennedy, Jr. “BARDA is terminating ...
Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 ...
In the second part of his Pharma Commerce video interview, Mark Lee, MarqVision’s founder and CEO, explains how wide regional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results